belinostat and Prostatic-Neoplasms

belinostat has been researched along with Prostatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for belinostat and Prostatic-Neoplasms

Article	Year
4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo. European journal of medicinal chemistry, 2017, Jul-07, Volume: 134 A series of 4,5-indolyl-N-hydroxyphenylacrylamides, as HDAC inhibitors, has been synthesized and evaluated in vitro and in vivo. 4-Indolyl compounds 13 and 17 functions as potent inhibitors of HDAC1 (IC Topics: Acrylamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Indoles; Male; Mice; Mice, Nude; Neoplasms; Prostate; Prostatic Neoplasms; Xenograft Model Antitumor Assays	2017

Article

Year

4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo.

European journal of medicinal chemistry, 2017, Jul-07, Volume: 134

A series of 4,5-indolyl-N-hydroxyphenylacrylamides, as HDAC inhibitors, has been synthesized and evaluated in vitro and in vivo. 4-Indolyl compounds 13 and 17 functions as potent inhibitors of HDAC1 (IC

Topics: Acrylamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Indoles; Male; Mice; Mice, Nude; Neoplasms; Prostate; Prostatic Neoplasms; Xenograft Model Antitumor Assays

2017